Urogenital atrophy.

In: Obstetrics and gynecology clinics of North America · 1987 · vol. 14(1) , pp. 13–32 · PMID:3627655 · W4302613762
article OA: closed CC0
View on OpenAlex View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-07-17

Urogenital atrophy, common in postmenopausal or castrated women, presents with varied symptoms due to age and estrogen loss, and estrogen replacement can alleviate symptoms with proper surveillance.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Urogenital atrophy in the postmenopausal or castrated woman is common with a multifactorial etiology and a varied clinical presentation. The effects of age and estrogen deprivation are, at times, poorly separable. Estrogen replacement may be used to significantly alleviate symptoms due to atrophy but must be used with appropriate surveillance to avoid potential adverse consequences.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK